These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 37801332)

  • 1. Design of 3-Phenylcoumarins and 3-Thienylcoumarins as Potent Xanthine Oxidase Inhibitors: Synthesis, Biological Evaluation, and Docking Studies.
    Fais A; Pintus F; Era B; Floris S; Kumar A; Sarmadhikari D; Sogos V; Uriarte E; Asthana S; Matos MJ
    ChemMedChem; 2023 Nov; 18(21):e202300400. PubMed ID: 37801332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coumarin derivatives as promising xanthine oxidase inhibitors.
    Fais A; Era B; Asthana S; Sogos V; Medda R; Santana L; Uriarte E; Matos MJ; Delogu F; Kumar A
    Int J Biol Macromol; 2018 Dec; 120(Pt A):1286-1293. PubMed ID: 30189275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis and biological evaluation of 1-alkyl-5/6-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)-1H-indole-3-carbonitriles as novel xanthine oxidase inhibitors.
    Gao J; Liu X; Zhang B; Mao Q; Zhang Z; Zou Q; Dai X; Wang S
    Eur J Med Chem; 2020 Mar; 190():112077. PubMed ID: 32014678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis and biological evaluation of novel xanthine oxidase inhibitors bearing a 2-arylbenzo[b]furan scaffold.
    Tang HJ; Li W; Zhou M; Peng LY; Wang JX; Li JH; Chen J
    Eur J Med Chem; 2018 May; 151():849-860. PubMed ID: 29684895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis, and biological evaluation of N-(3-cyano-1H-indol-5/6-yl)-6-oxo-1,6-dihydropyrimidine-4-carboxamides and 5-(6-oxo-1,6-dihydropyrimidin-2-yl)-1H-indole-3-carbonitriles as novel xanthine oxidase inhibitors.
    Zhang B; Duan Y; Yang Y; Mao Q; Lin F; Gao J; Dai X; Zhang P; Li Q; Li J; Dai R; Wang S
    Eur J Med Chem; 2022 Jan; 227():113928. PubMed ID: 34688012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel 3-[4-alkoxy-3-(1H-tetrazol-1-yl) phenyl]-1,2,4-oxadiazol-5(4H)-ones as promising xanthine oxidase inhibitors: Design, synthesis and biological evaluation.
    Gao J; Zhang Z; Zhang B; Mao Q; Dai X; Zou Q; Lei Y; Feng Y; Wang S
    Bioorg Chem; 2020 Jan; 95():103564. PubMed ID: 31927335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis, and biological evaluation of 5-(1H-indol-5-yl)isoxazole-3-carboxylic acids as novel xanthine oxidase inhibitors.
    Huang D; Li W; Zhao Y; Xie C; Luo X; Wu F; Xu Z; Sun Q; Liu G
    Eur J Med Chem; 2024 May; 271():116443. PubMed ID: 38691887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis, biological evaluation of 3,5-diaryl-4,5-dihydro-1H-pyrazole carbaldehydes as non-purine xanthine oxidase inhibitors: Tracing the anticancer mechanism via xanthine oxidase inhibition.
    Joshi G; Sharma M; Kalra S; Gavande NS; Singh S; Kumar R
    Bioorg Chem; 2021 Feb; 107():104620. PubMed ID: 33454509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and biological evaluation of thiazolidine-2-thione derivatives as novel xanthine oxidase inhibitors.
    Wang MX; Qin HW; Liu C; Lv SM; Chen JS; Wang CG; Chen YY; Wang JW; Sun JY; Liao ZX
    PLoS One; 2022; 17(5):e0268531. PubMed ID: 35584139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, screening and docking of fused pyrano[3,2-d]pyrimidine derivatives as xanthine oxidase inhibitor.
    Kaur M; Kaur A; Mankotia S; Singh H; Singh A; Singh JV; Gupta MK; Sharma S; Nepali K; Bedi PMS
    Eur J Med Chem; 2017 May; 131():14-28. PubMed ID: 28286211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, molecular docking and xanthine oxidase inhibitory activity of 5-aryl-1H-tetrazoles.
    Fatima I; Zafar H; Khan KM; Saad SM; Javaid S; Perveen S; Choudhary MI
    Bioorg Chem; 2018 Sep; 79():201-211. PubMed ID: 29772470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and evaluation of xanthine oxidase inhibitory and antioxidant activities of 2-arylbenzo[b]furan derivatives based on salvianolic acid C.
    Tang HJ; Zhang XW; Yang L; Li W; Li JH; Wang JX; Chen J
    Eur J Med Chem; 2016 Nov; 124():637-648. PubMed ID: 27614410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Looking for new xanthine oxidase inhibitors: 3-Phenylcoumarins versus 2-phenylbenzofurans.
    Era B; Delogu GL; Pintus F; Fais A; Gatto G; Uriarte E; Borges F; Kumar A; Matos MJ
    Int J Biol Macromol; 2020 Nov; 162():774-780. PubMed ID: 32574739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis and biological evaluation of N-(4-alkoxy-3-(1H-tetrazol-1-yl)phenyl) heterocyclic aromatic amide derivatives as xanthine oxidase inhibitors.
    Zhang TJ; Zhang ZH; Zhang X; Wang ZR; Xu EY; Tu S; Zhang Y; Meng FH
    Bioorg Chem; 2022 Oct; 127():105938. PubMed ID: 35752100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydroxylated chalcones with dual properties: Xanthine oxidase inhibitors and radical scavengers.
    Hofmann E; Webster J; Do T; Kline R; Snider L; Hauser Q; Higginbottom G; Campbell A; Ma L; Paula S
    Bioorg Med Chem; 2016 Feb; 24(4):578-87. PubMed ID: 26762836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Computational Analysis and Synthesis of Syringic Acid Derivatives as Xanthine Oxidase Inhibitors.
    Malik N; Khatkar A; Dhiman P
    Med Chem; 2020; 16(5):643-653. PubMed ID: 31584375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanistic approach towards interaction of newly synthesized Hesperidin derivatives against xanthine oxidase.
    Malik N; Dhiman P; Khatkar A
    Int J Biol Macromol; 2019 Aug; 135():864-876. PubMed ID: 31163243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-Activity Relationships and Docking Studies of Hydroxychavicol and Its Analogs as Xanthine Oxidase Inhibitors.
    Nishiwaki K; Ohigashi K; Deguchi T; Murata K; Nakamura S; Matsuda H; Nakanishi I
    Chem Pharm Bull (Tokyo); 2018 Jul; 66(7):741-747. PubMed ID: 29695658
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Gul A; Saad SM; Zafar H; Atia-Tul-Wahab ; Khan KM; Choudhary MI
    Med Chem; 2023; 19(4):384-392. PubMed ID: 35726432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intramolecular hydrogen bond interruption and scaffold hopping of TMC-5 led to 2-(4-alkoxy-3-cyanophenyl)pyrimidine-4/5-carboxylic acids and 6-(4-alkoxy-3-cyanophenyl)-1,2-dihydro-3H-pyrazolo[3,4-d]pyrimidin-3-ones as potent pyrimidine-based xanthine oxidase inhibitors.
    Zhao J; Mao Q; Lin F; Zhang B; Sun M; Zhang T; Wang S
    Eur J Med Chem; 2022 Feb; 229():114086. PubMed ID: 34992040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.